ArticleProbiotics and antimicrobial proteins2026
Genomic and Functional Characterization of Bacillus amyloliquefaciens H6: A Potent Fengycin-Producing Biocontrol Agent Against Fusarium graminearum.
Article in Probiotics and antimicrobial proteins, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Fusarium graminearum is a prominent pathogen responsible for global wheat scab, which not only leads to reduced yield and seed quality but also results in the production of diverse mycotoxins that persist on seeds, posing significant threats to both animal and human health. A bacterial strain, which exhibited a potent inhibitory effect on F. graminearum, was meticulously selected through dual culture and subsequently identified as Bacillus amyloliquefaciens H6 based on its morphological and physiological characteristics, as well as its whole-genome analysis. The antagonistic activity of H6 had been further studied antagonistic activity was further studied. Scanning electron microscopy and fluorescence microscopy revealed that the hypha in the inhibitory region was disrupted, resulting in contraction and deformation of the mycelium. Four out of seven lipopeptide extracts derived from the culture supernatant of B. amyloliquefaciens H6 demonstrated inhibitory effects on the growth of F. graminearum mycelium. MALDI-TOF-MS analysis revealed that the samples predominantly consisted of fengycin mixtures exhibiting diverse glycoside chains and configurations. The above results demonstrated that fengycin, produced by B. amyloliquefaciens H6, effectively inhibits F. graminearum. The biocontrol potential of this strain was further predicted by genomic analysis. The strain H6 exhibited significant potential for biological control in agriculture, making it a promising candidate for future applications.
Indexed as
Identifiers
42217152What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.